David Kerr contributes to Oxford as Professor of Cancer Medicine and Honorary Consultant medical oncologist, where he has worked with colleagues over the past 25 years to build a new Institute for Cancer Medicine and Cancer Hospital. He is an Honorary Professor of Oncology in Oslo and Sichuan Universities and Co-Director of Oxford-Sichuan Gastrointestinal Cancer Centre. He has an international reputation for the treatment of and research into cancer and the quality of his work has been recognised by the award of several national & international prizes, including the Tianfu Friendship Award (2022), the China Friendship Medal (2024), the Harvard Global Health Catalyst: Distinguished Leader Award, in recognition of his many years of leadership in global health work. He has published over 400 papers, has an H-Index of 115 associated with over 57,000 citations and is in the top 1-2 % of published cancer scientists. He was elected Fellow of the Academy of Medical Sciences and the European Academy of Cancer Sciences; Fellow of Royal Colleges of Physicians, Honorary Fellow of Royal College of General Practitioners; Fellow of Association of Cancer Physicians Fellow of European Society of Medical Oncology; Fellow of American Society of Clinical Oncology: appointed Commander of the British Empire and was elected President of the European Society of Medical Oncology in 2010.